hesperetin has been researched along with Acute Lung Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, C; Li, F; Liu, X; Sun, H; Wang, N; Wang, X | 1 |
| Chang, C; Dong, J; Zhao, H; Zhao, Y; Zhou, H | 1 |
| Guan, M; Li, C; Li, Y; Lu, Y; Ye, J; Zhang, D; Zhou, C | 1 |
3 other study(ies) available for hesperetin and Acute Lung Injury
| Article | Year |
|---|---|
Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4-MyD88-NF-κB signaling pathway.
Topics: Acute Lung Injury; Animals; Dose-Response Relationship, Drug; Hesperidin; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Hesperetin ameliorates lipopolysaccharide-induced acute lung injury via the miR-410/SOX18 axis.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Enzyme-Linked Immunosorbent Assay; Hesperidin; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; MicroRNAs; SOXF Transcription Factors | 2020 |
Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.
Topics: Acute Lung Injury; Animals; Cytoprotection; Gene Expression Regulation; Hesperidin; Humans; Lipopolysaccharides; Lung; Lymphocyte Antigen 96; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Targeted Therapy; Protein Conformation; RAW 264.7 Cells; Toll-Like Receptor 4 | 2019 |